Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Non Operating Income (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Non Operating Income for 6 consecutive years, with -$691000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 3190.48% to -$691000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$530000.0 through Dec 2025, down 121.4% year-over-year, with the annual reading at -$110000.0 for FY2025, 1.79% up from the prior year.
  • Non Operating Income hit -$691000.0 in Q4 2025 for Rapid Micro Biosystems, down from -$79000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $25.3 million in Q4 2021 to a low of -$12.8 million in Q3 2021.
  • Historically, Non Operating Income has averaged $397800.0 across 5 years, with a median of $142500.0 in 2022.
  • Biggest five-year swings in Non Operating Income: plummeted 95000.0% in 2021 and later soared 6300.0% in 2023.
  • Year by year, Non Operating Income stood at $25.3 million in 2021, then plummeted by 96.76% to $820000.0 in 2022, then surged by 411.34% to $4.2 million in 2023, then tumbled by 100.5% to -$21000.0 in 2024, then plummeted by 3190.48% to -$691000.0 in 2025.
  • Business Quant data shows Non Operating Income for RPID at -$691000.0 in Q4 2025, -$79000.0 in Q3 2025, and $301000.0 in Q2 2025.